Viatris is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally.

Viatris commenced Australian manufacture back in 1982 and now produces around 3.5 billion doses per year from its Carole Park, Queensland site, which are distributed in Australia and to more than 40 export markets. Approximately one in three Viatris medicines supplied to Australian patients are Australian made. 

With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris.